Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections

To study ocular hypertension (OHT) following intravitreal injections of bevacizumab and/or ranibizumab in patients with age-related macular degeneration (AMD). Retrospective case series. Patients with AMD who were treated at a tertiary referral center with intravitreal bevacizumab and/or ranibizumab...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of ocular pharmacology and therapeutics 2010-02, Vol.26 (1), p.105-110
Hauptverfasser:	ADELMAN, Ron A, QI ZHENG, MAYER, Hylton R
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized Bevacizumab Biological and medical sciences Drug Administration Schedule Drug Therapy, Combination Female Glaucoma and intraocular pressure Humans Injections, Intraocular Intraocular Pressure - drug effects Macular Degeneration - drug therapy Male Medical sciences Ocular Hypertension - chemically induced Ocular Hypertension - physiopathology Ophthalmology Pharmacology. Drug treatments Ranibizumab Retrospective Studies Time Factors Vascular Endothelial Growth Factor A - antagonists & inhibitors Vitreous Body
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!